Navigation Links
United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
Date:9/10/2007

UBC ClinResearch to Expand Global Reach in Pioneering Field

BETHESDA, Md., Sept. 10 /PRNewswire/ -- United BioSource Corporation (UBC) today announced the acquisition of an ownership interest in ClinResearch GmbH, a global leader in technology solutions and services for flexible, or adaptive, clinical trials. Headquartered in Cologne, Germany, with more than 100 employees, ClinResearch has designed and implemented 80 adaptive programs over the past seven years. ClinResearch's co-founder, Reinhard Eisebitt, is a co-developer of the leading software used by pharmaceutical companies and contract research organizations (CROs) throughout the world to support the rigorous statistical requirements of adaptive trials.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )

ClinResearch, which will now operate under the name UBC ClinResearch, will be a centerpiece of UBC's adaptive design clinical trial offering and will deliver a full service, global solution for pharmaceutical, biotechnology and medical device companies seeking to capitalize on the benefits of adaptive design in their clinical development strategy.

"We are thrilled to welcome ClinResearch to the UBC family," said Ethan Leder, CEO of UBC. "Having worked with the founders for several years, we know that they are an excellent fit with our culture and vision. They are innovative and science driven, and have built a world-class organization with a track record of developing and executing technology solutions that we plan to introduce aggressively to our growing base of sponsor and CRO clients."

"The interest in adaptive design is accelerating from the early adopter to the rapid growth stage. We are excited to be joining an organization with the resources to allow us to capitalize on this opportunity," noted Michael Fischer, PhD, founder of ClinResearch. Fischer added, "We are moving forward with expansion plans to fulfill demand on our global projects with UBC and anticipate growth in Cologne, as well as in our offices in Russia and the Ukraine to benefit our clients."

According to Patrick Lindsay, Executive Vice President of UBC, "ClinResearch's leadership in adaptive design is consistent with UBC's focus on innovative solutions for clinical development. Reinhard Eisebitt, ClinResearch's co-founder, is recognized by the FDA and European regulatory authorities as a thought leader in adaptive design based on the proprietary software and techniques that he helped develop. We look forward to bringing our combined strengths in this novel and quickly evolving methodology to the industry." The ClinResearch announcement is the latest in a series of transactions made since UBC raised $153 million in equity capital from a syndicate of leading private equity firms in 2003.

Since 1999, ClinResearch, GmbH, headquartered in Cologne, Germany, has been a leader in planning, conducting and reporting clinical studies for the pharmaceutical and medical device industries. For more information, visit http://www.clinresearch.com.

United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in offering new and innovative ways to study drugs and devices by offering expertise in science, strategy and execution.

UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Europe and South America. For more information, visit http://www.unitedbiosource.com or call 866-458-1096.

CONTACT: Tess Drahzal, +1 (240) 644-0420, info@unitedbiosource.com


'/>"/>
SOURCE United BioSource Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Inacom Education earns Wisconsin membership in United Training
2. Fiserv acquires crime management software firm
3. GenTel acquires GlaxoSmithKline chip platform
4. Tushaus Computer acquires managed service business
5. RedPrairie acquires Denver software company
6. Eagle Technology acquires some synergy
7. Brady Corp. acquires Korean counterpart
8. Canadian firm acquires Silicon Logic
9. Imago acquires synergistic British firm
10. Fiserv acquires insurance, training product lines
11. Amazon acquires Madison-based Shopbop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... has initiated a global Phase 2b induction study ... that targets alpha4beta7 integrin. The aim of this ... evaluate the safety/tolerability and efficacy of PTG-100 in ... to severe active disease. "We ...
(Date:1/16/2017)... , Jan. 16, 2017   Valentin A. Pavlov, ... MD , president and CEO of The Feinstein ... an analysis of how the nervous system regulates the ... develop bioelectronic medicine devices to treat disease ... Nature Neuroscience . The paper examines various ...
(Date:1/14/2017)... ... January 14, 2017 , ... Seattle-based Phase ... end-to-end genome assemblies to researchers around the globe. Long considered a “holy ... answering a wide range of scientific questions. The announcement was made today ...
(Date:1/13/2017)... Research and Markets has announced the addition of the "Global Biopolymers ... ... of 16.83% during the period 2017-2021. The report covers ... for 2017-2021. To calculate the market size, the report considers the revenue ... includes a a discussion of the key vendors operating in this market. ...
Breaking Biology Technology:
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/15/2016)... LONDON , Dec. 15, 2016 /PRNewswire/ ... the driving experience, health wellness and wellbeing ... As one in three new passenger vehicles ... voice recognition, gesture recognition, heart beat monitoring, ... eyelid monitoring, facial monitoring, and pulse detection. ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the growth of ... expected to grow from USD 4.03 billion in 2015 ... of 29.3% between 2016 and 2022. The market is ... smart devices, government initiatives, and increasing penetration of e-commerce ... to grow at a high rate during the forecast ...
Breaking Biology News(10 mins):